2017

Discovery of potent Bruton’s tyrosine kinase inhibitors using ligand based modeling

mkhanfar, 645, Journal Article, , Discovery of potent Bruton’s tyrosine kinase inhibitors using ligand based modeling. (2017). Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017, 17, 265–275.

2017

Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling

mkhanfar, 645, Journal Article, , Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling. (2017). Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 17, 265–275.

2017

Proteinease inhibition, membrane stabilization, antioxidant and phytochemical evaluations of leaves, seeds and calyces of four selected edible medicinal plants

amustapha, 990, Journal Article, , Proteinease inhibition, membrane stabilization, antioxidant and phytochemical evaluations of leaves, seeds and calyces of four selected edible medicinal plants. (2017). Cogent Chemistry 3 (1), 1314064, 2017.

2017

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

mkhanfar, 645, Journal Article, , 6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer. (2017). Medicinal Chemistry Research 26 (7), 1397-1404, 2017, 26, 1397–1404.

2017

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

mkhanfar, 645, Journal Article, , 6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer. (2017). Medicinal Chemistry Research, 26, 1397–1404.

2017

Abstract P110: low Intensity stimulation of Aortic Baroreceptors as a potential therapeutic alternative for hypertension treatment

isalman, 854, Journal Article, , Abstract P110: low Intensity stimulation of Aortic Baroreceptors as a potential therapeutic alternative for hypertension treatment. (2017). Hypertension 70 (suppl_1), AP110-AP110, 2017.

2017

Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors. (2017). Journal of Molecular Recognition 30 (9), e2623, 2017, 30, e2623.

2017

A prodrug approach to enhance azelaic acid percutaneous availability

mkhanfar, 645, Journal Article, , A prodrug approach to enhance azelaic acid percutaneous availability. (2017). Pharmaceutical Development and Technology 22 (4), 578-586, 2017, 22, 578–586.

2017

Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors. (2017). Journal of Molecular Recognition, 30, e2623.

2017

Allopurinol and arterial stiffness-what do we know so far? Journal of Pharmacology and Therapeutic Research 1(1): 1

malem, 159, Journal Article, , Allopurinol and arterial stiffness-what do we know so far? Journal of Pharmacology and Therapeutic Research 1(1): 1. (2017). Journal of Pharmacology and Therapeutic Research.